Related references
Note: Only part of the references are listed.Efficacy and safety of methylene blue in the treatment of malaria: a systematic review
G. Lu et al.
BMC MEDICINE (2018)
Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised controlled trial
Alassane Dicko et al.
LANCET INFECTIOUS DISEASES (2018)
Potent Ex Vivo Activity of Naphthoquine and Methylene Blue against Drug-Resistant Clinical Isolates of Plasmodium falciparum and Plasmodium vivax
Grennady Wirjanata et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Efficacy and Safety of Triple Combination Therapy With Artesunate-Amodiaquine-Methylene Blue for Falciparum Malaria in Children: A Randomized Controlled Trial in Burkina Faso
Boubacar Coulibaly et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Evolution from double to triple-antimalarial drug combinations
G. Dennis Shanks et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2015)
Efficacy of intravenous methylene blue, intravenous artesunate, and their combination in preclinical models of malaria
Colin Ohrt et al.
MALARIA JOURNAL (2014)
Haemolysis risk in methylene blue treatment of G6PD-sufficient and G6PD-deficient West-African children with uncomplicated falciparum malaria: a synopsis of four RCTs
Olaf Mueller et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2013)
In Vitro Activity of Proveblue (Methylene Blue) on Plasmodium falciparum Strains Resistant to Standard Antimalarial Drugs
Aurelie Pascual et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Lest we forget you - methylene blue ...
R. Heiner Schirmer et al.
NEUROBIOLOGY OF AGING (2011)
Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue
Sophie H. Adjalley et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial
Frank Smithuis et al.
LANCET INFECTIOUS DISEASES (2010)
A dose-finding study of methylene blue to inhibit nitric oxide actions in the hemodynamics of human septic shock
Nicole P. Juffermans et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2010)
Efficacy of methylene blue monotherapy in semi-immune adults with uncomplicated falciparum malaria: a controlled trial in Burkina Faso
Mamadou Bountogo et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2010)
High absolute bioavailability of methylene blue given as an aqueous oral formulation
Ingeborg Walter-Sack et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Artemisinin resistance on the Thai–Cambodian border
Olaf Müller et al.
LANCET (2009)
Strong Gametocytocidal Effect of Methylene Blue-Based Combination Therapy against Falciparum Malaria: A Randomised Controlled Trial
Boubacar Coulibaly et al.
PLOS ONE (2009)
Blood schizontocidal activity of methylene blue in combination with antimalarials against Plasmodium falciparum
G. Garavito et al.
PARASITE (2007)
In vitro assessment of methylene blue on chloroquine-sensitive and -resistant Plasmodium falciparum strains reveals synergistic action with artemisinins
M Akoachere et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Methylene blue-treated fresh-frozen plasma: what is its contribution to blood safety?
LM Williamson et al.
TRANSFUSION (2003)
Methylene blue as an antimalarial agent
RH Schirmer et al.
REDOX REPORT (2003)
Pharmacokinetics and organ distribution of intravenous and oral methylene blue
C Peter et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2000)
Share Paper
